Published in Am J Physiol on April 01, 1993
Application of isotopic techniques using constant specific activity or enrichment to the study of carbohydrate metabolism. Diabetes (2009) 1.04
Assessment of insulin action and glucose effectiveness in diabetic and nondiabetic humans. J Clin Invest (1994) 0.98
The effects of non-insulin-dependent diabetes mellitus on the kinetics of onset of insulin action in hepatic and extrahepatic tissues. J Clin Invest (1995) 0.87
On the calculation of glucose rate of disappearance in nonsteady state. Am J Physiol (1994) 0.81
Accurate Measurement of Postprandial Glucose Turnover: Why Is It Difficult and How Can It Be Done (Relatively) Simply? Diabetes (2016) 0.75
A multiple testing procedure for clinical trials. Biometrics (1979) 26.80
Prediction of AD with MRI-based hippocampal volume in mild cognitive impairment. Neurology (1999) 9.86
Medial temporal atrophy on MRI in normal aging and very mild Alzheimer's disease. Neurology (1997) 8.50
The clinical course of neuromyelitis optica (Devic's syndrome). Neurology (1999) 8.03
Quantitative estimation of insulin sensitivity. Am J Physiol (1979) 7.37
Procedures for comparing samples with multiple endpoints. Biometrics (1984) 6.70
Comparison of different MRI brain atrophy rate measures with clinical disease progression in AD. Neurology (2004) 5.86
Physiologic evaluation of factors controlling glucose tolerance in man: measurement of insulin sensitivity and beta-cell glucose sensitivity from the response to intravenous glucose. J Clin Invest (1981) 5.82
Brain atrophy rates predict subsequent clinical conversion in normal elderly and amnestic MCI. Neurology (2005) 5.02
Rates of hippocampal atrophy correlate with change in clinical status in aging and AD. Neurology (2000) 4.89
MR-based hippocampal volumetry in the diagnosis of Alzheimer's disease. Neurology (1992) 4.87
Sustained beta cell apoptosis in patients with long-standing type 1 diabetes: indirect evidence for islet regeneration? Diabetologia (2005) 4.61
Antemortem MRI findings correlate with hippocampal neuropathology in typical aging and dementia. Neurology (2002) 4.50
Role of chemotaxis in the association of motile bacteria with intestinal mucosa: in vivo studies. Infect Immun (1981) 4.34
The prevalence by staged severity of various types of diabetic neuropathy, retinopathy, and nephropathy in a population-based cohort: the Rochester Diabetic Neuropathy Study. Neurology (1993) 4.18
Trauma and multiple sclerosis: a population-based cohort study from Olmsted County, Minnesota. Neurology (1993) 4.04
Rate of medial temporal lobe atrophy in typical aging and Alzheimer's disease. Neurology (1998) 3.90
Functioning insulinoma--incidence, recurrence, and long-term survival of patients: a 60-year study. Mayo Clin Proc (1991) 3.88
Usefulness of MRI measures of entorhinal cortex versus hippocampus in AD. Neurology (2000) 3.84
Designs for group sequential tests. Control Clin Trials (1984) 3.56
Segmental demyelination secondary to axonal degeneration in uremic neuropathy. Mayo Clin Proc (1971) 3.35
Dose-response characteristics for effects of insulin on production and utilization of glucose in man. Am J Physiol (1981) 3.30
Verifying the stroke-free phenotype by structured telephone interview. Stroke (2000) 3.15
The Autonomic Symptom Profile: a new instrument to assess autonomic symptoms. Neurology (1999) 3.09
Oral glucose tolerance test minimal model indexes of beta-cell function and insulin sensitivity. Diabetes (2001) 3.05
Atrophy rates accelerate in amnestic mild cognitive impairment. Neurology (2007) 2.93
Adaptive changes in pancreatic beta cell fractional area and beta cell turnover in human pregnancy. Diabetologia (2010) 2.91
MRI as a biomarker of disease progression in a therapeutic trial of milameline for AD. Neurology (2003) 2.88
Effect of age and gender on sudomotor and cardiovagal function and blood pressure response to tilt in normal subjects. Muscle Nerve (1997) 2.86
Role of chemotaxis in the association of motile bacteria with intestinal mucosa: in vitro studies. Infect Immun (1981) 2.76
Human diabetic endoneurial sorbitol, fructose, and myo-inositol related to sural nerve morphometry. Ann Neurol (1980) 2.75
Liver iron stores in patients with non-insulin-dependent diabetes mellitus. Mayo Clin Proc (1994) 2.71
Limitations of quantitative sensory testing when patients are biased toward a bad outcome. Neurology (1998) 2.70
A randomized trial of plasma exchange in acute central nervous system inflammatory demyelinating disease. Ann Neurol (1999) 2.69
Influence of body fat distribution on free fatty acid metabolism in obesity. J Clin Invest (1989) 2.69
Memory and MRI-based hippocampal volumes in aging and AD. Neurology (2000) 2.65
SAAM II: Simulation, Analysis, and Modeling Software for tracer and pharmacokinetic studies. Metabolism (1998) 2.65
Value of autonomic testing in reflex sympathetic dystrophy. Mayo Clin Proc (1995) 2.65
Risk of dementia among persons with diabetes mellitus: a population-based cohort study. Am J Epidemiol (1997) 2.60
Pancreas volumes in humans from birth to age one hundred taking into account sex, obesity, and presence of type-2 diabetes. Clin Anat (2007) 2.58
Use and costs of medical care for children and adolescents with and without attention-deficit/hyperactivity disorder. JAMA (2001) 2.53
Pseudomyxoma peritonei. Long-term patient survival with an aggressive regional approach. Ann Surg (1994) 2.50
Cortisol-induced insulin resistance in man: impaired suppression of glucose production and stimulation of glucose utilization due to a postreceptor detect of insulin action. J Clin Endocrinol Metab (1982) 2.45
Variables influencing neuropathic endpoints: the Rochester Diabetic Neuropathy Study of Healthy Subjects. Neurology (1995) 2.42
1H MR spectroscopy in common dementias. Neurology (2004) 2.39
Role of chemotaxis in the association of motile bacteria with intestinal mucosa: fitness and virulence of nonchemotactic Vibrio cholerae mutants in infant mice. Infect Immun (1981) 2.39
Health care utilization in multiple sclerosis: a population-based study in Olmsted County, MN. Neurology (1998) 2.38
Global identifiability of nonlinear models of biological systems. IEEE Trans Biomed Eng (2001) 2.33
Impact of referral bias on clinical and epidemiological studies of Alzheimer's disease. J Clin Epidemiol (1996) 2.27
Regional metabolic patterns in mild cognitive impairment and Alzheimer's disease: A 1H MRS study. Neurology (2000) 2.26
FLAIR histogram segmentation for measurement of leukoaraiosis volume. J Magn Reson Imaging (2001) 2.24
Longitudinal assessment of diabetic polyneuropathy using a composite score in the Rochester Diabetic Neuropathy Study cohort. Neurology (1997) 2.23
Generalized sensitivity functions in physiological system identification. Ann Biomed Eng (1999) 2.15
Lack of suppression of glucagon contributes to postprandial hyperglycemia in subjects with type 2 diabetes mellitus. J Clin Endocrinol Metab (2000) 2.15
Comparison of memory fMRI response among normal, MCI, and Alzheimer's patients. Neurology (2003) 2.10
C-peptide: a redundant relative of insulin? Diabetologia (2007) 2.01
Role of chemotaxis in the association of motile bacteria with intestinal mucosa: chemotactic responses of Vibrio cholerae and description of motile nonchemotactic mutants. Infect Immun (1981) 1.97
Cardiac surgery in the octogenarian: perioperative outcome and clinical follow-up. J Am Coll Cardiol (1991) 1.96
The value of thymectomy in myasthenia gravis: a computer-assisted matched study. Ann Surg (1976) 1.93
Mild cognitive impairment and Alzheimer disease: regional diffusivity of water. Radiology (2001) 1.92
The role of growth hormone in the development of diabetic retinopathy. Diabetes Care (1994) 1.91
The appropriateness of analysis of variance and multiple-comparison procedures. Biometrics (1983) 1.89
Magnetic resonance imaging-based volume studies in temporal lobe epilepsy: pathological correlations. Ann Neurol (1991) 1.89
Hippocampal atrophy and apolipoprotein E genotype are independently associated with Alzheimer's disease. Ann Neurol (1998) 1.86
Effect of chemotaxis on the interaction of cholera vibrios with intestinal mucosa. Am J Clin Nutr (1979) 1.85
Epidemiologic correlates of sporadic amyotrophic lateral sclerosis. Neurology (1991) 1.84
A complete comparative chromosome map for the dog, red fox, and human and its integration with canine genetic maps. Genomics (1999) 1.79
Optic neuritis: a population-based study in Olmsted County, Minnesota. Neurology (1995) 1.78
Assessment of body composition with use of dual-energy x-ray absorptiometry: evaluation and comparison with other methods. Mayo Clin Proc (1993) 1.77
Methods for measuring plasma hemoglobin in micromolar concentration compared. Clin Chem (1992) 1.77
Prednisone improves chronic inflammatory demyelinating polyradiculoneuropathy more than no treatment. Ann Neurol (1982) 1.77
Strontium absorption and excretion in normocalciuric subjects: relation to calcium metabolism. Clin Chem (1998) 1.76
Risk factors for severity of diabetic polyneuropathy: intensive longitudinal assessment of the Rochester Diabetic Neuropathy Study cohort. Diabetes Care (1999) 1.74
Modestly increased beta cell apoptosis but no increased beta cell replication in recent-onset type 1 diabetic patients who died of diabetic ketoacidosis. Diabetologia (2007) 1.73
Mechanism and significance of insulin resistance in non-insulin-dependent diabetes mellitus. Diabetes (1981) 1.73
Population-based study of the incidence of sudden unexplained death in epilepsy. Neurology (1998) 1.72
Adrenergic mechanisms for the effects of epinephrine on glucose production and clearance in man. J Clin Invest (1980) 1.71
A telemedicine support for diabetes management: the T-IDDM project. Comput Methods Programs Biomed (2002) 1.69
Parameter and structural identifiability concepts and ambiguities: a critical review and analysis. Am J Physiol (1980) 1.69
A plasma exchange versus immune globulin infusion trial in chronic inflammatory demyelinating polyradiculoneuropathy. Ann Neurol (1994) 1.68
Quantitative estimation of beta cell sensitivity to glucose in the intact organism: a minimal model of insulin kinetics in the dog. Diabetes (1980) 1.67
Saturable transport of insulin from plasma into the central nervous system of dogs in vivo. A mechanism for regulated insulin delivery to the brain. J Clin Invest (1993) 1.67
Postprandial hyperglycemia in patients with noninsulin-dependent diabetes mellitus. Role of hepatic and extrahepatic tissues. J Clin Invest (1986) 1.61
Modular closed-loop control of diabetes. IEEE Trans Biomed Eng (2012) 1.61
Effects of type 2 diabetes on the ability of insulin and glucose to regulate splanchnic and muscle glucose metabolism: evidence for a defect in hepatic glucokinase activity. Diabetes (2000) 1.60
Levodopa therapy and survival in idiopathic Parkinson's disease: Olmsted County project. Neurology (1993) 1.57
Direct assessment of liver glycogen storage by 13C nuclear magnetic resonance spectroscopy and regulation of glucose homeostasis after a mixed meal in normal subjects. J Clin Invest (1996) 1.57
Pain in peripheral neuropathy related to rate and kind of fiber degeneration. Neurology (1976) 1.53
Ovarian cancer identification based on dimensionality reduction for high-throughput mass spectrometry data. Bioinformatics (2005) 1.52
Is the minimal model too minimal? Diabetologia (1996) 1.52
Population-based study of seizure disorders after cerebral infarction. Neurology (1996) 1.52
Effect of insulin on the distribution and disposition of glucose in man. J Clin Invest (1985) 1.49
Magnetic resonance image-based hippocampal volumetry: correlation with outcome after temporal lobectomy. Ann Neurol (1992) 1.49
Are we optimizing gestational diabetes treatment with glyburide? The pharmacologic basis for better clinical practice. Clin Pharmacol Ther (2009) 1.48
Theophylline effect on sleep in normal subjects. Chest (1993) 1.47
Roles of glucose transport and glucose phosphorylation in muscle insulin resistance of NIDDM. Diabetes (1996) 1.46